41 related articles for article (PubMed ID: 27982429)
1. MicroRNA-125a-5p Is a Downstream Effector of Sorafenib in Its Antiproliferative Activity Toward Human Hepatocellular Carcinoma Cells.
Potenza N; Mosca N; Zappavigna S; Castiello F; Panella M; Ferri C; Vanacore D; Giordano A; Stiuso P; Caraglia M; Russo A
J Cell Physiol; 2017 Jul; 232(7):1907-1913. PubMed ID: 27982429
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.
Bai S; Nasser MW; Wang B; Hsu SH; Datta J; Kutay H; Yadav A; Nuovo G; Kumar P; Ghoshal K
J Biol Chem; 2009 Nov; 284(46):32015-27. PubMed ID: 19726678
[TBL] [Abstract][Full Text] [Related]
3. A Novel ceRNET Relying on the lncRNA JPX, miR-378a-3p, and Its mRNA Targets in Lung Cancer.
Mosca N; Pezzullo M; De Leo I; Truda A; Marchese G; Russo A; Potenza N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672608
[TBL] [Abstract][Full Text] [Related]
4. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma.
Mosca N; Russo A; Potenza N
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240232
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma.
Lu Y; Chan YT; Tan HY; Zhang C; Guo W; Xu Y; Sharma R; Chen ZS; Zheng YC; Wang N; Feng Y
J Exp Clin Cancer Res; 2022 Jan; 41(1):3. PubMed ID: 34980204
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate Alters the Expression of microRNA in Fibroblast-like Synovial Cells in Rheumatoid Arthritis.
Iwamoto N; Furukawa K; Endo Y; Shimizu T; Sumiyoshi R; Umeda M; Koga T; Kawashiri SY; Igawa T; Ichinose K; Tamai M; Origuchi T; Kawakami A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768991
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0061395 accelerates hepatocellular carcinoma progression via regulation of the miR-877-5p/PIK3R3 axis.
Yu Y; Bian L; Liu R; Wang Y; Xiao X
Cancer Cell Int; 2021 Jan; 21(1):10. PubMed ID: 33407443
[TBL] [Abstract][Full Text] [Related]
8. The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.
Karbasforooshan H; Hayes AW; Mohammadzadeh N; Zirak MR; Karimi G
Cell Cycle; 2020 Dec; 19(23):3209-3221. PubMed ID: 33164623
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA‑125a‑5p regulates liver cancer cell growth, migration and invasion and EMT by targeting HAX1.
Zha Z; Li J
Int J Mol Med; 2020 Nov; 46(5):1849-1861. PubMed ID: 33000203
[TBL] [Abstract][Full Text] [Related]
10. A Novel ceRNA Regulatory Network Involving the Long Non-Coding Antisense RNA SPACA6P-AS, miR-125a and its mRNA Targets in Hepatocarcinoma Cells.
Di Palo A; Siniscalchi C; Mosca N; Russo A; Potenza N
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709089
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNA MRUL Contributes to Osteosarcoma Progression Through the miR-125a-5p/FUT4 Axis.
Tian C; Sun X; Han K; Zhu H; Min D; Lin S
Front Genet; 2020; 11():672. PubMed ID: 32670359
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects.
Tang W; Chen Z; Zhang W; Cheng Y; Zhang B; Wu F; Wang Q; Wang S; Rong D; Reiter FP; De Toni EN; Wang X
Signal Transduct Target Ther; 2020 Jun; 5(1):87. PubMed ID: 32532960
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.
Lai Y; Feng B; Abudoureyimu M; Zhi Y; Zhou H; Wang T; Chu X; Chen P; Wang R
Front Oncol; 2019; 9():1156. PubMed ID: 31750247
[TBL] [Abstract][Full Text] [Related]
14. miR-22-3p is involved in gluconeogenic pathway modulated by 3,5-diiodo-L-thyronine (T2).
Senese R; Cioffi F; Petito G; de Lange P; Russo A; Goglia F; Lanni A; Potenza N
Sci Rep; 2019 Nov; 9(1):16645. PubMed ID: 31719576
[TBL] [Abstract][Full Text] [Related]
15. miR-125a-5p: a novel regulator of SLC26A6 expression in intestinal epithelial cells.
Anbazhagan AN; Priyamvada S; Borthakur A; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C200-C208. PubMed ID: 31042422
[TBL] [Abstract][Full Text] [Related]
16. miR-125a restrains cell migration and invasion by targeting STAT3 in gastric cancer cells.
Yang L; Zhang S; Guo K; Huang H; Qi S; Yao J; Zhang Z
Onco Targets Ther; 2019; 12():205-215. PubMed ID: 30636883
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma.
Sagnelli E; Potenza N; Onorato L; Sagnelli C; Coppola N; Russo A
World J Hepatol; 2018 Sep; 10(9):558-570. PubMed ID: 30310534
[TBL] [Abstract][Full Text] [Related]
18. ZBTB7A governs estrogen receptor alpha expression in breast cancer.
Molloy ME; Lewinska M; Williamson AK; Nguyen TT; Kuser-Abali G; Gong L; Yan J; Little JB; Pandolfi PP; Yuan ZM
J Mol Cell Biol; 2018 Aug; 10(4):273-284. PubMed ID: 30265334
[TBL] [Abstract][Full Text] [Related]
19. The Network of Non-coding RNAs in Cancer Drug Resistance.
Corrà F; Agnoletto C; Minotti L; Baldassari F; Volinia S
Front Oncol; 2018; 8():327. PubMed ID: 30211115
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
